GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
72.79
+9.97 (15.87%)
At close: Oct 8, 2025, 4:00 PM EDT
73.00
+0.21 (0.29%)
After-hours: Oct 8, 2025, 7:58 PM EDT
GRAIL Employees
GRAIL had 1,000 employees as of December 31, 2024. The number of employees decreased by 360 or -26.47% compared to the previous year.
Employees
1,000
Change (1Y)
-360
Growth (1Y)
-26.47%
Revenue / Employee
$134,285
Profits / Employee
-$442,952
Market Cap
2.62B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GRAL News
- 8 days ago - Grail: A Speculative Buy - Seeking Alpha
- 15 days ago - GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC - PRNewsWire
- 19 days ago - Sun World International and Pairwise Launch Strategic Partnership to Develop a Holy Grail of Produce – the Pitless Cherry - GlobeNewsWire
- 4 weeks ago - GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum - PRNewsWire
- 4 weeks ago - GRAIL, Inc. (GRAL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - mRNA Biotechs - Long-Term Value Risks Abound - Seeking Alpha
- 6 weeks ago - GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference - PRNewsWire